Rubenstein David M. Insider Trading Activity (MRNA)

Summary

Updated Jul 16, 2026

Rubenstein David M. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $23.34M.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-04	MRNA	Moderna, Inc.	M — Option exercise	8.1K	—
2026-03-20	CG	Carlyle Group Inc.	S — Open-market sale	500.0K	$46.68	$23.34M
2026-03-20	CG	Carlyle Group Inc.	G — Bona-fide gift	100.0K	$0.00
2025-08-05	MRNA	Moderna, Inc.	M — Option exercise	850	—

Frequently Asked Questions

Who is Rubenstein David M.?

Rubenstein David M. is a corporate insider — currently tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Rubenstein David M. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Rubenstein David M. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($23.34M) across all tracked filings.

Where can I see all of Rubenstein David M.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Rubenstein David M. — SEC Form 4 Insider Trading Activity